Skip to main content

Table 2 Clinicopathological features of bladder cancers in HCV-infected patients and non-infected patients

From: Impact of Hepatitis C Virus (HCV) infection on biomolecular markers influencing the pathogenesis of bladder cancer

Criteria

HCV infected patients

Non-HCV patients

P value

Age

57.6±8.59

57.9±9.45

NS

Minimum = 36

Minimum = 42

Maximum = 79

Maximum = 80

Sex

   

- Male

43 (86%)

42 (84%)

NS

- Female

7 (14%)

8 (16%)

 

Histopathological type

   

- TCC

32 (64%)

19 (38%)

p= 0.009

- SCC

18 (36%)

31 (62%)

 

Tumour grade

   

- Grade I

10 (20%)

26 (52%)

p= 0.000

- Grade II

19 (38%)

19 (38%)

 

- Grade III

21 (42%)

5 (10%)

 

Lymph Nodes (LNs)

   

- Negative LNs

38 (76%)

40 (80%)

NS

- Positive LNs

12 (24 %)

10 (20%)

 

Tumour staging

   

- Stage (Ta)

1 (2%)

5 (10%)

p= 0.002

- Stage (T1)

12 (24%)

17 (34%)

 

- Stage (T2)

13 (26%)

15 (30%)

 

- Stage (T3)

12 (24%)

8 (16%)

 

- Stage (T4)

12 (24%)

5 (10%)

 

Metastases

   

- Negative

43 (86%)

42 (84%)

NS

- Positive

7 (14%)

8 (16%)

 
  1. P= chi square test with significance of p ≤ 0.05.